Risk Factors of Mortality and Long-Term Survival in Burn Patients With/Without Extracorporeal Membrane Oxygenation: A 16 Year Real-World Study.

IF 3.1 3区 医学 Q2 ENGINEERING, BIOMEDICAL
ASAIO Journal Pub Date : 2024-12-01 Epub Date: 2024-05-28 DOI:10.1097/MAT.0000000000002244
Po-Shun Hsu, Jiun-Yu Lin, Yi-Ting Tsai, Chih-Yuan Lin, Jia-Lin Chen, Wu-Chien Chien, Chien-Sung Tsai
{"title":"Risk Factors of Mortality and Long-Term Survival in Burn Patients With/Without Extracorporeal Membrane Oxygenation: A 16 Year Real-World Study.","authors":"Po-Shun Hsu, Jiun-Yu Lin, Yi-Ting Tsai, Chih-Yuan Lin, Jia-Lin Chen, Wu-Chien Chien, Chien-Sung Tsai","doi":"10.1097/MAT.0000000000002244","DOIUrl":null,"url":null,"abstract":"<p><p>Burn patients face cardiopulmonary failure risks, with recent observational studies suggesting promising outcomes for extracorporeal membrane oxygenation (ECMO). However, the effectiveness and long-term survival remain unclear. Our study aims to assess mortality risk factors and long-term survival in burn patients with and without ECMO. This study used Taiwan's National Health Insurance Research Database and designed a case-control with onefold propensity score matching across variables including sex, age, total body surface area (TBSA) burned, and index date. We analyzed mortality and survival risk factors in each stratified group with/without ECMO. Finally, we analyze the mortality according to ECMO and TBSA burned, and the cause of death and long-term survival. From 2000 to 2015, 4,556 burn patients with ECMO compared to an equivalent number without ECMO. Primary mortality include male, age >65, TBSA ≥30%, escharotomy, hemodialysis, and bacteremia. The ECMO group showed lower survival across all stratified risk factors, with the primary cause of death being burn-related issues, followed by respiratory and heart failure. The overall mortality rate was 54.41% with ECMO and 40.94% without ECMO ( p < 0.001). Additionally, long-term survival is lower in the group with ECMO. This research provides a valuable real-world gross report about ECMO efficacy and long-term survival among burn patients with/without ECMO.</p>","PeriodicalId":8844,"journal":{"name":"ASAIO Journal","volume":" ","pages":"1049-1059"},"PeriodicalIF":3.1000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11594556/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ASAIO Journal","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1097/MAT.0000000000002244","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/5/28 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0

Abstract

Burn patients face cardiopulmonary failure risks, with recent observational studies suggesting promising outcomes for extracorporeal membrane oxygenation (ECMO). However, the effectiveness and long-term survival remain unclear. Our study aims to assess mortality risk factors and long-term survival in burn patients with and without ECMO. This study used Taiwan's National Health Insurance Research Database and designed a case-control with onefold propensity score matching across variables including sex, age, total body surface area (TBSA) burned, and index date. We analyzed mortality and survival risk factors in each stratified group with/without ECMO. Finally, we analyze the mortality according to ECMO and TBSA burned, and the cause of death and long-term survival. From 2000 to 2015, 4,556 burn patients with ECMO compared to an equivalent number without ECMO. Primary mortality include male, age >65, TBSA ≥30%, escharotomy, hemodialysis, and bacteremia. The ECMO group showed lower survival across all stratified risk factors, with the primary cause of death being burn-related issues, followed by respiratory and heart failure. The overall mortality rate was 54.41% with ECMO and 40.94% without ECMO ( p < 0.001). Additionally, long-term survival is lower in the group with ECMO. This research provides a valuable real-world gross report about ECMO efficacy and long-term survival among burn patients with/without ECMO.

使用/未使用体外膜氧合技术的烧伤患者死亡率和长期存活率的风险因素:一项为期 16 年的真实世界研究。
烧伤患者面临心肺功能衰竭的风险,最近的观察性研究表明,体外膜肺氧合(ECMO)具有良好的效果。然而,其有效性和长期存活率仍不明确。我们的研究旨在评估使用和未使用 ECMO 的烧伤患者的死亡风险因素和长期存活率。本研究使用了台湾国民健康保险研究数据库,并设计了一个病例对照,对性别、年龄、烧伤总体表面积(TBSA)和指数日期等变量进行了一倍倾向评分匹配。我们分析了使用/未使用 ECMO 的各分层组的死亡率和存活风险因素。最后,我们根据 ECMO 和烧伤总体表面积分析了死亡率、死亡原因和长期存活率。从 2000 年到 2015 年,4556 名烧伤患者接受了 ECMO 治疗,而未接受 ECMO 治疗的患者人数相当。主要死亡原因包括男性、年龄大于 65 岁、TBSA ≥30%、烧伤切除术、血液透析和菌血症。在所有分层风险因素中,ECMO 组的存活率较低,主要死因是烧伤相关问题,其次是呼吸衰竭和心力衰竭。使用 ECMO 的总死亡率为 54.41%,未使用 ECMO 的总死亡率为 40.94%(P < 0.001)。此外,使用 ECMO 组的长期存活率较低。这项研究提供了一份有价值的真实世界总报告,介绍了使用或未使用 ECMO 的烧伤患者的 ECMO 疗效和长期存活率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
ASAIO Journal
ASAIO Journal 医学-工程:生物医学
CiteScore
6.60
自引率
7.10%
发文量
651
审稿时长
4-8 weeks
期刊介绍: ASAIO Journal is in the forefront of artificial organ research and development. On the cutting edge of innovative technology, it features peer-reviewed articles of the highest quality that describe research, development, the most recent advances in the design of artificial organ devices and findings from initial testing. Bimonthly, the ASAIO Journal features state-of-the-art investigations, laboratory and clinical trials, and discussions and opinions from experts around the world. The official publication of the American Society for Artificial Internal Organs.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信